Laser Photonics (LASE) Q3 2024 earnings summary

Executive summary

• Completed acquisition of Control Micro Systems (CMS), expanding into healthcare and pharmaceutical sectors and diversifying revenue streams.

• Strategic investments in HR, sales, and administration increased costs but are aimed at supporting long-term growth.

• Advanced R&D in laser wafer dicing, 3D metal additive manufacturing, anti-drone systems, and robotic cells.

• Closed key deals in non-destructive testing, defense, and renewable energy markets, including Acuren, U.S. Navy, and Brokk partnership in Asia-Pacific.

• Revenue for Q3 2024 was $716,697–$800,000, down from $1,303,205 in Q3 2023, mainly due to timing of orders.

Financial highlights

• Revenue declined 22% year-over-year to $716,697–$800,000 but rose 21% sequentially from the previous quarter.

• Gross margin improved to 85–85.8%, driven by favorable product mix.

• Operating expenses increased to $2,315,317, up 25% year-over-year, due to investments in personnel and higher G&A.

• Operating loss widened to $1.4–$1.7 million; net loss increased to $1.6 million from $0.9 million year-over-year.

• Loss per share increased to $0.13 from $0.11, with share count rising to 13.3 million after capital raise and license acquisition.

Outlook and guidance

• CMS acquisition expected to add over $2 million in unbilled contracted revenue, to be converted in coming quarters.

• Management expects some delayed orders from Q3 2024 to be booked in Q4 2024, potentially improving future revenue.

• Anticipates continued growth in CleanTech orders, backlog expansion into 2025, and future growth from innovative product launches.

• Focus remains on integrating CMS and leveraging synergies for scalability and revenue growth.

• Ongoing investments in R&D and sales/marketing are planned to support long-term growth and product innovation.